1. Home
  2. AEVA vs CADL Comparison

AEVA vs CADL Comparison

Compare AEVA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeva Technologies Inc.

AEVA

Aeva Technologies Inc.

N/A

Current Price

$14.28

Market Cap

1.1B

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$10.26

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEVA
CADL
Founded
2019
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AEVA
CADL
Price
$14.28
$10.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
★ $30.00
$21.75
AVG Volume (30 Days)
★ 1.2M
979.5K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.53
★ 58.62
EPS
N/A
★ N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
$78.97
N/A
Revenue Next Year
$124.76
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.83
$4.35
52 Week High
$31.30
$14.00

Technical Indicators

Market Signals
Indicator
AEVA
CADL
Relative Strength Index (RSI) 38.47 40.32
Support Level $13.95 $9.40
Resistance Level $14.30 $10.59
Average True Range (ATR) 0.81 0.67
MACD 0.05 -0.12
Stochastic Oscillator 11.26 7.71

Price Performance

Historical Comparison
AEVA
CADL

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: